Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease
Cure51, a Techbio company seeking to unlock the biological mechanisms responsible for exceptional survivors among cancer patients, today announced that it has successfully raised €15 million in a seed funding...